What is Qualtex?
Qualtex Laboratories, founded in 2007 and headquartered in San Antonio, Texas, is a specialized testing laboratory. The company provides critical blood and plasma screening, reference testing, and clinical research services. Its offerings cater to patients, donors, and the regulatory oversight of biological products. Services include whole blood donor screening, infectious disease testing, source plasma donor screening, and HCT/P donor screening for human cells, tissues, eyes, organs, and cellular and tissue-based products. Additionally, Qualtex offers immunohematology reference laboratory services and specialty testing, such as potency assays, clinical research/trials, non-FDA licensed assays, and research and development. The company operates testing facilities in San Antonio, Texas, and Norcross, Georgia, functioning as a subsidiary of BioBridge Global.
How much funding has Qualtex raised?
Qualtex has raised a total of $850K across 2 funding rounds:
Debt
$350K
Debt
$500K
Debt (2020): $350K with participation from PPP
Debt (2021): $500K led by PPP
Key Investors in Qualtex
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Qualtex?
The recent major strategic investment in Qualtex Laboratories signals a period of accelerated growth and potential expansion of its testing capabilities. This capital infusion is likely to bolster its capacity to serve the growing demand for reliable blood and plasma screening, reference testing, and clinical research services. The company's focus on regulated biological products and its subsidiary status within BioBridge Global suggest a strategic alignment with broader healthcare and biotechnology initiatives. Future developments may involve enhanced technological integration, expanded service offerings, or strategic partnerships to further solidify its market position in the vital field of biological product safety and research.
See full Qualtex company page
